Related references
Note: Only part of the references are listed.Optimizing soy isoflavones effect in postmenopausal women: the impact of timing on climacteric symptoms
Maria Jesus Cancelo Hidalgo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
Nonestrogenic Management of Hot Flashes
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effectiveness of a Herbal Formula in Women with Menopausal Syndrome
Mostafa Yakoot et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2011)
Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
Louise Bordeleau et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause
Winfried G. Rossmanith et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause
Margaret Diana van Die et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Mental workload under time pressure can trigger frequent hot flashes in menopausal women
Mi Kyong Park et al.
INDUSTRIAL HEALTH (2008)
The effect of vitamin e on hot flashes in menopausal women
S. Ziaei et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2007)
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
Dan J. Stein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women
RC Thurston et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE (2006)
Conjugated equine estrogens and global cognitive function in postmenopausal women - Women's Health Initiative Memory Study
MA Espeland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the study of women's health across the nation
EB Gold et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure - a randomised controlled study
P Vestergaard et al.
MATURITAS (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women
JA Conquer et al.
LIPIDS (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Hormone replacement therapy at the threshold of 21st century
D Panidis et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
Placebos, placebo effect, and the response to the healing situation: The evolution of a concept
YG Papakostas et al.
EPILEPSIA (2001)
The hot flash related daily interference scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer
JS Carpenter
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2001)
Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women:: two randomized controlled trials of Efacal® v. calcium alone
EJ Bassey et al.
BRITISH JOURNAL OF NUTRITION (2000)
Share Paper
